SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-001820
Filing Date
2023-01-10
Accepted
2023-01-10 06:22:14
Documents
14
Period of Report
2023-01-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0171455-8k_augmedix.htm   iXBRL 8-K 26284
2 PRESS RELEASE DATED JANUARY 9, 2023 ANNOUNCING PRELIMINARY FOURTH QUARTER 2022 F ea0171455ex99-1_augmedix.htm EX-99.1 19207
3 GRAPHIC image_001.jpg GRAPHIC 3355
  Complete submission text file 0001213900-23-001820.txt   231755

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE augx-20230109.xsd EX-101.SCH 3227
5 XBRL LABEL FILE augx-20230109_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE augx-20230109_pre.xml EX-101.PRE 22359
8 EXTRACTED XBRL INSTANCE DOCUMENT ea0171455-8k_augmedix_htm.xml XML 3712
Mailing Address 111 SUTTER STREET, SUITE 1300 SAN FRANCISC CA 94104
Business Address 111 SUTTER STREET, SUITE 1300 SAN FRANCISC CA 94104 561-989-2208
Augmedix, Inc. (Filer) CIK: 0001769804 (see all company filings)

IRS No.: 833299164 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40890 | Film No.: 23519637
SIC: 7389 Services-Business Services, NEC